SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001654954-24-004314
Filing Date
2024-04-08
Accepted
2024-04-08 06:14:02
Documents
1
Period of Report
2024-04-08

Document Format Files

Seq Description Document Type Size
1 ENHERTU APPROVED IN US FOR HER2+ SOLID TUMOURS astrazenecaplc-5918j.htm 6-K 68074
  Complete submission text file 0001654954-24-004314.txt   69279
Mailing Address 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE X0 CB2 0AA
Business Address 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE X0 CB2 0AA 011 44 20 7304 5000
ASTRAZENECA PLC (Filer) CIK: 0000901832 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-11960 | Film No.: 24828037
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)